• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Sight Sciences raises $10m in Series C

Sight Sciences raises $10m in Series C

October 11, 2017 By Fink Densford

Sigh Sciences

Ophthalmic medical device company Sight Sciences said this week it closed a $10 million oversubscribed Series C round to support expanding manufacturing and its US commercial team and the launch of its devices into the dry eye and microinvasive surgery markets.

The round was led by Allegro Investment Fund and was joined with full participation from existing Series A and Series B investors, the Menlo Park, Calif.-based company said. As part of the funding around, Allegro’s chairman Steffan Encrantz will join the company’s board of directors as chair.

Funds are also slated to support expanding the company’s product indications and strategic product positioning.

“Allegro has supported Sight Sciences from the beginning, and we have witnessed its technology platforms mature into breakthrough products that eye care providers confidently use to care for their patients. We look forward to supporting the Sight team as they work to elevate the standard of care globally in both glaucoma and dry eye, two diseases in need of high-yield innovation and more effective solutions,” Allegro Investment chair Encrantz said in a press release.

“We are excited to partner with Allegro and welcome Staffan Encrantz to our board of directors as Chairman. Allegro is a skilled growth investor with a long-term view and strong history of supporting innovative companies like Sight Sciences as we achieve commercial scale and market leadership,” prez & CEO Paul Badawi said in a prepared statement.

Sight Sciences said that, unrelated to the funding round, it tapped 20-year Alcon vet Shawn O’Niel as its senior VP of sales and marketing.

“Shawn brings a wealth of valuable industry knowledge and an extensive professional network from his long and successful career at Alcon. He is perfectly suited to lead our upcoming product launches and commercial scale-up and will make a substantial impact in creating value for all Sight Sciences stakeholders – patients, providers, payors, and shareholders. With Shawn’s addition to our leadership team and the closing of an oversubscribed round led by our seasoned growth capital investor, we are excited to take our commercial efforts to the next level,” CEO Badawi said in a prepared release.

Last December, Sight Sciences said it won Health Canada approval for its TRAB 360 trabeculotomy system.

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: Sight Sciences

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy